Skip to main content

Treatment gaps in the pharmacologic management of heart failure.

Publication ,  Journal Article
Gheorghiade, M; Gattis, WA; O'Connor, CM
Published in: Rev Cardiovasc Med
2002

Chronic heart failure continues to increase in incidence and prevalence despite many pharmacologic advances over the previous decade. Morbidity and mortality remain high, with the number of hospitalizations for worsening heart failure in 1999 approaching 1 million. In addition to investigation of new therapies for the treatment of heart failure, attention must be placed on identifying effective methods for increasing the adoption of proven therapies. First, the potential barriers to implementation of evidence-based medicine must be recognized. Subsequently, strategies to overcome such barriers can be developed. Published guidelines may be helpful in educating practitioners on current standards of care. Other tools may also be considered, and testing the influence of such tools on the implementation of optimal therapy may help the scientific community better understand the factors that influence decision-making among clinicians.

Duke Scholars

Published In

Rev Cardiovasc Med

ISSN

1530-6550

Publication Date

2002

Volume

3 Suppl 3

Start / End Page

S11 / S19

Location

Singapore

Related Subject Headings

  • Treatment Outcome
  • Practice Patterns, Physicians'
  • Practice Guidelines as Topic
  • Incidence
  • Humans
  • Heart Failure
  • Health Knowledge, Attitudes, Practice
  • Evidence-Based Medicine
  • Cardiovascular System & Hematology
  • Angiotensin-Converting Enzyme Inhibitors
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gheorghiade, M., Gattis, W. A., & O’Connor, C. M. (2002). Treatment gaps in the pharmacologic management of heart failure. Rev Cardiovasc Med, 3 Suppl 3, S11–S19.
Gheorghiade, Mihai, Wendy A. Gattis, and Christopher M. O’Connor. “Treatment gaps in the pharmacologic management of heart failure.Rev Cardiovasc Med 3 Suppl 3 (2002): S11–19.
Gheorghiade M, Gattis WA, O’Connor CM. Treatment gaps in the pharmacologic management of heart failure. Rev Cardiovasc Med. 2002;3 Suppl 3:S11–9.
Gheorghiade, Mihai, et al. “Treatment gaps in the pharmacologic management of heart failure.Rev Cardiovasc Med, vol. 3 Suppl 3, 2002, pp. S11–19.
Gheorghiade M, Gattis WA, O’Connor CM. Treatment gaps in the pharmacologic management of heart failure. Rev Cardiovasc Med. 2002;3 Suppl 3:S11–S19.

Published In

Rev Cardiovasc Med

ISSN

1530-6550

Publication Date

2002

Volume

3 Suppl 3

Start / End Page

S11 / S19

Location

Singapore

Related Subject Headings

  • Treatment Outcome
  • Practice Patterns, Physicians'
  • Practice Guidelines as Topic
  • Incidence
  • Humans
  • Heart Failure
  • Health Knowledge, Attitudes, Practice
  • Evidence-Based Medicine
  • Cardiovascular System & Hematology
  • Angiotensin-Converting Enzyme Inhibitors